After the Kobayashi Pharmaceutical Red Yeast Rice Turmoil,
Another scandal broke out in Japanese pharmaceutical companies.
This time, it is the drugstore's Internet celebrity "miracle medicine" Zhenglu Pill.
Image source: Screenshot of the official website of Japan's Far East Company
A few days ago, the Japanese pharmaceutical company "Far East" was ordered to stop production and sales by the Toyama County Government for 23 days and 22 days respectively due to the production of insufficient ingredients of the gastrointestinal drug "Zhenglu Pill" and then falsifying data for shipment. The decision will be formally implemented on April 30.
According to reports, the Far East falsified drug test data for 30 years.
In the face of questions from the public and interested parties, Far East admitted that it had been tampering with drug trial results since 30 years ago, and apologized for its lack of awareness of compliance with regulations. The company pledged to take the incident seriously, work to restore consumer trust, and thoroughly investigate to prevent similar incidents from happening again.
It is reported that with a history of more than 100 years, Shoro Maru has long been advertised as a "cure for gastrointestinal discomfort", and has been sold well both in Japan and abroad. In Japan, Shoro Maru is a Class II pharmaceutical product that is used in many households and is manufactured by several pharmaceutical companies in Japan.
So far, the company has independently recalled 5.16 million copies of Zhenglu pills that went to the market.
Netizens were stunned:
"From snacks to big ones
Japan Shoromaru Metropolitan Emergency"
Source: Xiamen Daily, Finance Associated Press, netizen comments, etc